title: Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
authors.forename: B
authors.initials: B
authors.lastname: Oran
authors.forename: S
authors.initials: S
authors.lastname: Giralt
authors.forename: D
authors.initials: D
authors.lastname: Couriel
authors.forename: C
authors.initials: C
authors.lastname: Hosing
authors.forename: E J
authors.initials: EJ
authors.lastname: Shpall
authors.forename: E
authors.initials: E
authors.lastname: de Meis
authors.forename: I F
authors.initials: IF
authors.lastname: Khouri
authors.forename: M
authors.initials: M
authors.lastname: Qazilbash
authors.forename: P
authors.initials: P
authors.lastname: Anderlini
authors.forename: P
authors.initials: P
authors.lastname: Kebriaei
authors.forename: U
authors.initials: U
authors.lastname: Popat
authors.forename: A
authors.initials: A
authors.lastname: Carrasco-Yalan
authors.forename: R E
authors.initials: RE
authors.lastname: Champlin
authors.forename: M
authors.initials: M
authors.lastname: de Lima
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000706:statistics & numerical data; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D017710:Lymphocyte Transfusion / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D019653:Myeloablative Agonists / Q000008:administration & dosage; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D010166:Palliative Care; D012008:Recurrence; D012074:Remission Induction; D016879:Salvage Therapy; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D019653:Myeloablative Agonists